BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33524287)

  • 1. Fluoroquinolones vs. amoxicillin-clavulanate or ampicillin-sulbactam were not linked to aortic aneurysm or dissection.
    Fekete T
    Ann Intern Med; 2021 Feb; 174(2):JC22. PubMed ID: 33524287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
    Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
    J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concerns About Fluoroquinolones and Aortic Aneurysm.
    Aschenbrenner DS
    Am J Nurs; 2021 May; 121(5):24. PubMed ID: 33872257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of aortic aneurysm and aortic dissection with the use of fluoroquinolones in Korea: a nested case-control study.
    Son N; Choi E; Chung SY; Han SY; Kim B
    BMC Cardiovasc Disord; 2022 Feb; 22(1):44. PubMed ID: 35152888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis.
    Wee I; Chin B; Syn N; Lee KS; Ng JJ; Choong AMTL
    Sci Rep; 2021 May; 11(1):11073. PubMed ID: 34040146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What Fluoroquinolones Have the Highest Risk of Aortic Aneurysm? A Case/Non-case Study in VigiBase®.
    Sommet A; Bénévent J; Rousseau V; Chebane L; Douros A; Montastruc JL; Montastruc F
    J Gen Intern Med; 2019 Apr; 34(4):502-503. PubMed ID: 30565153
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluoroquinolones and the Risk of Aortic Aneurysm or Aortic Dissection: A Systematic Review and Meta-Analysis.
    Rawla P; El Helou ML; Vellipuram AR
    Cardiovasc Hematol Agents Med Chem; 2019; 17(1):3-10. PubMed ID: 30947680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis.
    Singh S; Nautiyal A
    Am J Med; 2017 Dec; 130(12):1449-1457.e9. PubMed ID: 28739200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.
    Latif A; Ahsan MJ; Kapoor V; Lateef N; Malik SU; Patel AD; Khan BA; Bittner M; Holmberg M
    WMJ; 2020 Sep; 119(3):185-189. PubMed ID: 33091293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.
    Dong YH; Chang CH; Wang JL; Wu LC; Lin JW; Toh S
    JAMA Intern Med; 2020 Dec; 180(12):1587-1595. PubMed ID: 32897358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population-based propensity score-matched cohort study.
    Garg M; Venugopalan V; Vouri SM; Diaby V; Iovine NM; Park H
    Pharmacotherapy; 2023 Sep; 43(9):883-893. PubMed ID: 37381584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Fluoroquinolone Use and Hospitalization With Aortic Aneurysm or Aortic Dissection.
    Brown JP; Wing K; Leyrat C; Evans SJ; Mansfield KE; Wong AYS; Smeeth L; Galwey NW; Douglas IJ
    JAMA Cardiol; 2023 Sep; 8(9):865-870. PubMed ID: 37585175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serious side effects of fluoroquinolones: low risk of connective tissue-related disorders such as aneurysms].
    Boes J; Dofferhoff ASM; Fleuren HWHA; Kramers C
    Ned Tijdschr Geneeskd; 2020 Nov; 164():. PubMed ID: 33332024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
    Jun C; Fang B
    BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolones and Risk of Aortic Aneurysm or Dissection in Patients With Congenital Aortic Disease and Marfan Syndrome.
    Chen SW; Lin CP; Chan YH; Wu VC; Cheng YT; Tung YC; Hsiao FC; Chen DY; Hung KC; Chou AH; Chu PH
    Circ J; 2023 Aug; 87(9):1164-1172. PubMed ID: 36823078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ampicillin-sulbactam and amoxicillin-clavulanate susceptibility testing of Escherichia coli isolates with different beta-lactam resistance phenotypes.
    Oliver A; Pérez-Vázquez M; Martínez-Ferrer M; Baquero F; De Rafael L; Cantón R
    Antimicrob Agents Chemother; 1999 Apr; 43(4):862-7. PubMed ID: 10103192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Use of Fluoroquinolones and Risk of Mitral or Aortic Valve Regurgitation: A Nationwide Cohort Study.
    Dong YH; Wang JL; Chang CH; Lin JW; Chen YA; Chen CY; Toh S
    Clin Pharmacol Ther; 2024 Jan; 115(1):147-157. PubMed ID: 37926942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Intracranial Aneurysm and Dissection and Fluoroquinolone Use: A Case-Time-Control Study.
    Maumus-Robert S; Debette S; Bérard X; Mansiaux Y; Tubert-Bitter P; Pariente A
    Stroke; 2020 Mar; 51(3):994-997. PubMed ID: 31964291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Aortic Dissection and Aortic Aneurysm in Patients Taking Oral Fluoroquinolone.
    Lee CC; Lee MT; Chen YS; Lee SH; Chen YS; Chen SC; Chang SC
    JAMA Intern Med; 2015 Nov; 175(11):1839-47. PubMed ID: 26436523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Not Available].
    Pulz S
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2016 Sep; 51(9):514-5. PubMed ID: 27631440
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.